Publication
PS-42: CGA Position Statement on Appropriate and Effective Regulations for Medical Gases within 21 CFR Parts 201, 205, and 210/211
This position statement reflects the Compressed Gas Association’s (CGA) consensus position for how the FDA’s regulations for finished pharmaceuticals found in Title 21 of the U.S. Code of Federal Regulations (21 CFR) Parts 201 (labeling), 205 (wholesale distribution), and 210 and 211 (GMPs), should be revised for designated medical gases or combinations thereof. This position is consistent with established and long standing industry practice yielding safe and efficacious designated medical gases and consistent with the Congressional intent in the FDASIA identifying the need for revisions to 21 CFR.
Member Price:
$63
Suscriber Price:
$63
Non-Member Price:
$115

Member E-Pub Price:
$0
Suscriber E-Pub Price:
$0
Non-Member E-Pub Price:
$115
Buy Hard Copy
Purchase E-Pub

To download and read publications, you must have the following software installed:

 
Edition:
3
Published:
January 2018
Status:
Available To the Public
Size:
44 pages
Publisher:
CGA
Special Attributes:
Notes:
Committee:
Medical Gases
Keywords
Related